$POAI
Predictive Oncology Inc. Stock $poai

$poai Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000114420414018035 Filed on March 27, 2014

Income Statement

Concept	2013 Q4	2013	2012 Q4
Revenue	$80.00K	$468.1K	$90.00K
YoY Change	-11.11%	147.98%	28.57%
Cost Of Revenue	$50.00K	$189.7K	$40.00K
YoY Change	25.0%	47.59%	0.0%
Gross Profit	$30.00K	$278.4K	$50.00K
YoY Change	-40.0%	362.24%	66.67%
Gross Profit Margin	37.5%	59.48%	55.56%
Selling, General & Admin	$1.840M	$8.109M	$1.350M
YoY Change	36.3%	25.55%	-48.67%
% of Gross Profit	6133.33%	2912.47%	2700.0%
Research & Development		$235.0K
YoY Change		1466.67%
% of Gross Profit		84.41%
Depreciation & Amortization	-$10.00K	$148.8K	$0.00
YoY Change		13686.93%
% of Gross Profit	-33.33%	53.43%	0.0%
Operating Expenses	$2.190M	$8.344M	$1.600M
YoY Change	36.88%	28.88%	-37.98%
Operating Profit	-$2.160M	-$8.065M	-$1.550M
YoY Change	39.35%	25.75%	-39.22%
Interest Expense	$0.00	$636.5K	-$170.0K
YoY Change	-100.0%	145.42%	-59.52%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.150M	-$9.410M	-$1.720M
YoY Change	25.0%	26.82%	-42.09%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.150M	-$9.406M	-$1.720M
YoY Change	25.0%	26.73%	-42.09%
Net Earnings / Revenue	-2687.5%	-2009.36%	-1911.11%
Basic Earnings Per Share
Diluted Earnings Per Share	-$215.0M	-$941.0M	-$172.0M
COMMON SHARES
Basic Shares Outstanding		2.026M shares
Diluted Shares Outstanding		152.0M shares

Balance Sheet

Concept	2013 Q4	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.0K	$100.0K	$10.00K
YoY Change	900.0%	900.0%	-91.67%
Cash & Equivalents	$102.0K		$13.14K
Short-Term Investments
Other Short-Term Assets	$60.00K	$60.00K	$30.00K
YoY Change	100.0%	100.0%	0.0%
Inventory	$122.2K	$120.0K	$145.2K
Prepaid Expenses
Receivables	$97.25K	$100.0K	$39.71K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$382.0K	$380.0K	$225.5K
YoY Change	69.41%	65.22%	-24.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$158.1K	$160.0K	$3.521K
YoY Change	4390.49%
Goodwill
YoY Change
Intangibles	$53.36K		$140.6K
YoY Change	-62.05%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$211.5K	$210.0K	$144.1K
YoY Change	46.74%	50.0%	-3.93%
TOTAL ASSETS
Total Short-Term Assets	$382.0K	$380.0K	$225.5K
Total Long-Term Assets	$211.5K	$210.0K	$144.1K
Total Assets	$593.4K	$590.0K	$369.6K
YoY Change	60.57%	59.46%	-17.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.062M	$1.060M	$733.6K
YoY Change	44.78%	45.21%	0.49%
Accrued Expenses	$2.058M	$2.060M	$1.600M
YoY Change	28.66%	28.75%	180.62%
Deferred Revenue
YoY Change
Short-Term Debt	$280.0K	$280.0K	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$1.080M
YoY Change	-100.0%	-100.0%	1.89%
Total Short-Term Liabilities	$3.469M	$3.470M	$3.414M
YoY Change	1.6%	1.76%	45.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$89.30K
YoY Change	-100.0%	-100.0%	-85.83%
Other Long-Term Liabilities	$340.0K	$340.0K	$170.0K
YoY Change	100.0%	100.0%	0.0%
Total Long-Term Liabilities	$0.00	$340.0K	$89.30K
YoY Change	-100.0%	30.77%	-88.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.469M	$3.470M	$3.414M
Total Long-Term Liabilities	$0.00	$340.0K	$89.30K
Total Liabilities	$3.812M	$3.810M	$3.673M
YoY Change	3.79%	3.81%	16.6%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$25.48M		$15.99M
YoY Change	59.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.218M	-$3.220M	-$3.303M
YoY Change
Total Liabilities & Shareholders Equity	$593.4K	$590.0K	$369.6K
YoY Change	60.57%	59.46%	-17.87%

Cashflow Statement

Concept	2013 Q4	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$2.150M	-$9.406M	-$1.720M
YoY Change	25.0%	26.73%	-42.09%
Depreciation, Depletion And Amortization	-$10.00K	$148.8K	$0.00
YoY Change		13686.93%
Cash From Operating Activities	-$520.0K	-$3.860M	-$400.0K
YoY Change	30.0%	227.12%	-32.2%
INVESTING ACTIVITIES
Capital Expenditures	-$120.0K	$162.8K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$120.0K	-$220.0K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.337M
YoY Change		235.93%
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	410.0K	4.160M	310.0K
YoY Change	32.26%	288.79%	-52.31%
NET CHANGE
Cash From Operating Activities	-520.0K	-3.860M	-400.0K
Cash From Investing Activities	-120.0K	-220.0K	0.000
Cash From Financing Activities	410.0K	4.160M	310.0K
Net Change In Cash	-230.0K	80.00K	-90.00K
YoY Change	155.56%	-172.73%	-250.0%
FREE CASH FLOW
Cash From Operating Activities	-$520.0K	-$3.860M	-$400.0K
Capital Expenditures	-$120.0K	$162.8K	$0.00
Free Cash Flow	-$400.0K	-$4.023M	-$400.0K
YoY Change	0.0%	240.91%	-32.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39711	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	145209	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3521	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	122175	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27409	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	381961	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	158110	USD
CY2013Q4	us-gaap	Assets Assets	593426	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	60588	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53355	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13139	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101953	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	97245	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	169179	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	11599	USD
CY2012Q4	us-gaap	Liabilities Liabilities	3672780	USD
CY2013Q4	us-gaap	Liabilities Liabilities	3811880	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	1042473	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2199376	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14945435	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	23279585	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	225468	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Accounting Policies and Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	140588	USD
CY2012Q4	us-gaap	Assets Assets	369577	USD
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1081187	USD
CY2013Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	733595	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1062108	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1599519	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2057957	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	69000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3414301	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3469065	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	89300	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2012Q4	skln	Accrued Liabilities Non Current AccruedLiabilitiesNonCurrent	0	USD
CY2013Q4	skln	Accrued Liabilities Non Current AccruedLiabilitiesNonCurrent	331216	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	19291111	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	28697415	USD
CY2013	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	1823000	USD
	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	3935000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-3303203	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-3218454	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	369577	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	593426	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	39543	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	18603	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	14658	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	46754	USD
CY2013	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	2337000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	6956000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	91008	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	56818	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	235000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	140588	USD
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	219937619	shares
	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	1.67
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4073	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2012Q4	skln	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	21138	USD
CY2013Q4	skln	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2009Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	100000	USD
CY2010Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	16800	USD
CY2011Q1	skln	Warrants Issued During Period Shares In Connection With Convertible Debt WarrantsIssuedDuringPeriodSharesInConnectionWithConvertibleDebt	1595239	shares
CY2010Q2	skln	Warrants Issued During Period Shares In Connection With Convertible Debt WarrantsIssuedDuringPeriodSharesInConnectionWithConvertibleDebt	1111112	shares
CY2010Q3	skln	Warrants Issued During Period Shares In Connection With Convertible Debt WarrantsIssuedDuringPeriodSharesInConnectionWithConvertibleDebt	320000	shares
CY2009Q4	skln	Warrants Issued During Period Shares In Connection With Convertible Debt WarrantsIssuedDuringPeriodSharesInConnectionWithConvertibleDebt	200000	shares
CY2010Q4	skln	Warrants Issued During Period Shares In Connection With Convertible Debt WarrantsIssuedDuringPeriodSharesInConnectionWithConvertibleDebt	200000	shares
CY2011Q1	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.20
CY2010Q2	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.46
CY2010Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.18
CY2009Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.65
CY2012Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.10
CY2010Q4	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.084
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	27658652	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.085
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y9M18D
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104247228	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	219937619	shares
CY2008	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.020	pure
CY2008	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.045	pure
CY2008	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2008	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.53	pure
CY2008	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.66	pure
CY2007Q1	skln	Convertible Debt Issuance Of Warrants ConvertibleDebtIssuanceOfWarrants	100000	USD
CY2013	skln	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Volatility Description ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityDescription	The Company compiled historical volatilities over a period of 2 to 7 years of 15 small-cap medical companies traded on major exchanges and 10 mid-range medical companies on the OTC Bulletin Board and combined the results using a weighted average approach.
CY2011Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	47908	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	275640	USD
CY2007Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	40242	USD
CY2010Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	96613	USD
CY2007Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	92700	USD
CY2010Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	15553	USD
CY2009Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	30150	USD
CY2012Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	33469	USD
CY2010Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7232	USD
CY2011Q1	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P24M
CY2007Q1	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P5Y
CY2010Q2	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P22M
CY2010Q3	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P18M
CY2009Q4	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P24M
CY2010Q4	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P24M
CY2007Q3	skln	Convertible Bridge Debt Issuance Of Warrants ConvertibleBridgeDebtIssuanceOfWarrants	170000	USD
CY2007Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2008-04-30
CY2011Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	50000	USD
CY2010Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	200000	USD
CY2010Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	32000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	830372	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3700070	USD
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	166905	USD
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P22M
CY2011	skln	Value Of Equity Instruments Issued With Debt In Fourth Quarter ValueOfEquityInstrumentsIssuedWithDebtInFourthQuarter	47908	USD
CY2012	skln	Value Of Equity Instruments Issued With Debt In Fourth Quarter ValueOfEquityInstrumentsIssuedWithDebtInFourthQuarter	33469	USD
CY2008	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	Under theterms of the Company's agreement with investors in the October 2008 financing, 1,920,000 shares of common stock were the maximum number of shares allocated to the Company's existing shareholders at the time of the offering (also referred to as the original shareholders or the "Founders"). Since the total of the Company's fully diluted shares of common stock was greater than 1,920,000 shares, in order for the Company to proceed with the offering, the Board of Directors approved a reverse stock split of 1-for-1.2545. After this split was approved, additional options and warrants were identified, requiring a second reverse stock split in order to reach the 1,920,000 shares. The second reverse stock split on the reduced 1-for-1.2545 balance was determined to be 1-for-1.33176963. Taken together, if only one reverse stock split was performed, the number would have been a reverse stock split of 1-for-1.670705. On June 6, 2008, the Board of Directors approved the first reverse stock split. The authorized number of shares of common stock of 20,000,000 was proportionately divided by 1.2545 to arrive at 15,942,607. On October 20, 2008, the Board of Directors (i) approved the second reverse stock split pursuant to which the authorized number of shares of common stock of 15,942,607 was proportionately divided by 1.33177 to arrive at 11,970,994 shares and (ii) approved a resolution to increase the number of authorized shares of the Company's common stock from 11,970,994 to 40,000,000, which was approved by the Companys shareholders holding a majority of the shares entitled to vote thereon at a special meeting of shareholders held on December 3, 2008.
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2010Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2011Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q1	skln	Convertible Note Conversion Price ConvertibleNoteConversionPrice	0.12
CY2012Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	156243	USD
CY2013Q1	skln	Convertible Notes Converted Into Common Stock ConvertibleNotesConvertedIntoCommonStock	2500000	shares
CY2013Q2	skln	Convertible Notes Converted Into Common Stock ConvertibleNotesConvertedIntoCommonStock	1116084	shares
CY2013Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.12
CY2013Q1	skln	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	77644	USD
CY2013Q1	skln	Number Of Shares Issued Under Ppm To Five Investors NumberOfSharesIssuedUnderPpmToFiveInvestors	7142857	shares
CY2013Q1	skln	Number Of Shares Issued Under Ppm To Five Investors NumberOfSharesIssuedUnderPpmToFiveInvestors	7142858	shares
CY2013Q1	skln	Par Value Of Common Stock Issued Under Ppm To Five Investors ParValueOfCommonStockIssuedUnderPpmToFiveInvestors	0.07
CY2013Q1	skln	Par Value Of Common Stock Issued Under Ppm To Five Investors ParValueOfCommonStockIssuedUnderPpmToFiveInvestors	0.07
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	skln	Warrants Exercise Price WarrantsExercisePrice	0.08
CY2013Q2	skln	Warrants Exercise Price WarrantsExercisePrice	0.10
CY2013Q2	skln	Warrants Exercise Price WarrantsExercisePrice	0.18
CY2013Q3	skln	Warrants Exercise Price WarrantsExercisePrice	0.10
CY2013Q4	skln	Warrants Exercise Price WarrantsExercisePrice	0.25
	skln	Warrants Issued To Purchase Common Stock WarrantsIssuedToPurchaseCommonStock	444444	shares
CY2012Q4	skln	Debt Instrument Interest DebtInstrumentInterest	11169	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	357163	shares
CY2013Q1	skln	Commonstocksharesissuedtoconsultantexercisingoptions Commonstocksharesissuedtoconsultantexercisingoptions	200000	shares
CY2013Q2	skln	Commonstocksharesissuedtoconsultantexercisingoptions Commonstocksharesissuedtoconsultantexercisingoptions	200000	shares
CY2013Q2	skln	Common Stock Issued To Former Ceo Exercising Option Par Value CommonStockIssuedToFormerCeoExercisingOptionParValue	0.01
CY2013Q2	skln	Common Stock Issued To Former Consultant Exercising Option Par Value CommonStockIssuedToFormerConsultantExercisingOptionParValue	0.01
CY2013Q2	skln	Common Stock Shares Issued To Ceo Exercising Options CommonStockSharesIssuedToCeoExercisingOptions	333330	shares
CY2013Q3	skln	Stock Issued During Period Value Issued To Twenty Four Warrant Holders StockIssuedDuringPeriodValueIssuedToTwentyFourWarrantHolders	1044490	USD
CY2013Q3	skln	Stock Issued During Period Shares Issued To Twenty Four Warrant Holders StockIssuedDuringPeriodSharesIssuedToTwentyFourWarrantHolders	10444898	shares
CY2013Q3	skln	Issuance Of Net Exercise Provision Shares IssuanceOfNetExerciseProvisionShares	6533788	shares
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-7422155	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-9406304	USD
	us-gaap	Net Income Loss NetIncomeLoss	-28697415	USD
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69587814	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151958618	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18952512	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69587814	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151958618	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18952512	shares
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.51
CY2012Q4	skln	Options And Warrants Outstanding OptionsAndWarrantsOutstanding	47795702	USD
CY2013Q4	skln	Options And Warrants Outstanding OptionsAndWarrantsOutstanding	63583227	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2209000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3259000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	73000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	59000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2282000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3318000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2282000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3318000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013	skln	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	13969000	USD
CY2013	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2017-12-31
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	560874	USD
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2012Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	471574	USD
CY2013Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0	USD
CY2012	us-gaap	Interest Paid InterestPaid	31008	USD
CY2013	us-gaap	Interest Paid InterestPaid	55198	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	188772	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	468125	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	769559	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	128540	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	189707	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	381467	USD
CY2012	us-gaap	Gross Profit GrossProfit	60232	USD
CY2013	us-gaap	Gross Profit GrossProfit	278418	USD
	us-gaap	Gross Profit GrossProfit	388092	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6285905	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7530037	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23280400	USD
CY2012	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	761047	USD
CY2013	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1096969	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3387550	USD
CY2012	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	172970	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	578793	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1640248	USD
CY2012	us-gaap	Interest Expense InterestExpense	259349	USD
CY2013	us-gaap	Interest Expense InterestExpense	636503	USD
	us-gaap	Interest Expense InterestExpense	1562959	USD
CY2012	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-3116	USD
CY2013	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	157580	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	785650	USD
CY2012	skln	Operating And Non Operating Expenses Total OperatingAndNonOperatingExpensesTotal	7482387	USD
CY2013	skln	Operating And Non Operating Expenses Total OperatingAndNonOperatingExpensesTotal	9684722	USD
	skln	Operating And Non Operating Expenses Total OperatingAndNonOperatingExpensesTotal	29085507	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7422155	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9406304	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28697415	USD
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69587814	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	151958618	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18952512	shares
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	36000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	37000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	38000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	39000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3000	USD
CY2013	skln	Lease Period Extended LeasePeriodExtended	five years
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	45961	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	61150	USD
CY2013	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2018-01-31
CY2009Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	39743	USD
CY2010Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	25553	USD
CY2009Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	169854	USD
CY2012Q2	skln	Shares Issued Related Party Transactions One SharesIssuedRelatedPartyTransactionsOne	277778	shares
CY2013Q4	skln	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Stock Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice	0.35
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.769
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6M
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0013	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0297	pure
CY2008	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	479910	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	702205	USD
CY2010Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	31332	USD
CY2010Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	31506	USD
CY2009Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	12698	USD
CY2008	skln	Gain Loss On Warrants Issued GainLossOnWarrantsIssued	-390368	USD
	skln	Gain Loss On Warrants Issued GainLossOnWarrantsIssued	-369642	USD
CY2009Q2	skln	Gain Loss On Warrants Issued GainLossOnWarrantsIssued	20847	USD
CY2009Q3	skln	Gain Loss On Warrants Issued GainLossOnWarrantsIssued	-738	USD
CY2009Q4	skln	Gain Loss On Warrants Issued GainLossOnWarrantsIssued	617	USD
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	790596	USD
CY2009Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	479910	USD
CY2009	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M
CY2009Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	486564	USD
CY2009Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6654	USD
CY2009Q1	us-gaap	Liabilities Current LiabilitiesCurrent	479910	USD
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.63	pure
CY2009Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.46
CY2009Q4	skln	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Stock Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPrice	0.35
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
CY2012	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3000000	USD
CY2008Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	2000	USD
CY2012Q1	skln	Converible Note Percentage ConveribleNotePercentage	0.20	pure
CY2012Q3	skln	Converible Note Percentage ConveribleNotePercentage	0.20	pure
CY2012Q4	skln	Converible Note Percentage ConveribleNotePercentage	0.2	pure
CY2012Q1	skln	Converible Note Principal Amount ConveribleNotePrincipalAmount	240000	USD
CY2012Q3	skln	Converible Note Principal Amount ConveribleNotePrincipalAmount	600000	USD
CY2012Q4	skln	Converible Note Principal Amount ConveribleNotePrincipalAmount	156243	USD
CY2013Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.24	pure
CY2012Q1	skln	Cash Advance Net Of Interest CashAdvanceNetOfInterest	60000	USD
CY2012Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.065
CY2013Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2013Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.014
CY2012Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	600000	USD
CY2012Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1546667	shares
CY2012Q2	skln	Stock Transferred During Period StockTransferredDuringPeriod	7500000	shares
CY2012Q2	skln	Price Per Share Related Party Transactions PricePerShareRelatedPartyTransactions	0.09
CY2012Q2	skln	Compensation Issued In Lieu Of Cash CompensationIssuedInLieuOfCash	25000	USD
CY2012Q2	skln	Warrants Shares Related Party Transactions WarrantsSharesRelatedPartyTransactions	30000	shares
CY2012Q2	skln	Warrants Price Per Share Related Party Transactions WarrantsPricePerShareRelatedPartyTransactions	0.15
CY2012Q4	skln	Shares Issued Related Party Transactions Three SharesIssuedRelatedPartyTransactionsThree	1562430	shares
CY2012Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	155000	USD
CY2013Q2	skln	Convertible Note Due Date ConvertibleNoteDueDate	2013-08-31
CY2012	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	830372	USD
CY2013	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	(i) financing raising not less than $1 million, compensation of $75,000; (ii) a going private transaction, compensation of $200,000 or greater and (iii) 3% of the gross proceeds of the NASDAQ underwriting, which payment shall under no circumstances be less than $200,000 or greater than $3,000,000. In May 2013 Dr. Herschkowitz received $75,000 after the Company surpassed raising $1 million.
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1041622	shares
CY2013Q1	skln	Compensation Payment Pursuant To Merger CompensationPaymentPursuantToMerger	listing the Companys shares on NASDAQ pursuant to an underwritten offering of the Companys securities resulting in gross proceeds of between $5 million and $30 million, then the Company would have to be required to deliver to Dr. Herschkowitz the following compensation: (A) $75,000 upon consummating the shell merger, (B) $150,000 upon consummating the qualifying financing round and (C) 3% of the gross proceeds of the NASDAQ underwriting, which payment shall under no circumstances be less than $200,000 or greater than $1,000,000. The Company was also required to reimburse Dr. Herschkowitz at his actual out-of-pocket cost for reasonable expenses incurred in connection with the shell transactions, with a maximum limit of $10,000 for such expenses.
CY2013Q3	skln	Common Shares Received Per Share On Resignation CommonSharesReceivedPerShareOnResignation	0.325
CY2013Q3	skln	Compensation Received From Serving As Boards CompensationReceivedFromServingAsBoards	20000	shares
CY2013Q3	skln	Issuance Of Shares To Satisy Previous Contractual Agreements IssuanceOfSharesToSatisyPreviousContractualAgreements	30000	shares
CY2001Q4	us-gaap	Stockholders Equity StockholdersEquity	0	USD
CY2002	skln	Common Stock Issued To Founders During Period Value CommonStockIssuedToFoundersDuringPeriodValue	10000	USD
CY2003	skln	Common Stock Issued During Period Value Compensation For Loan Guarantees By Management CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement	400	USD
CY2005	skln	Common Stock Issued During Period Value Compensation For Loan Guarantees By Management CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement	250	USD
CY2007	skln	Common Stock Issued During Period Value Compensation For Loan Guarantees By Management CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement	1000	USD
CY2008	skln	Common Stock Issued During Period Value Compensation For Loan Guarantees By Management CommonStockIssuedDuringPeriodValueCompensationForLoanGuaranteesByManagement	1593502	USD
CY2003	skln	Common Stock Issued During Period Value Investment Including Finders Fee CommonStockIssuedDuringPeriodValueInvestmentIncludingFindersFee	35000	USD
CY2004	skln	Common Stock Issued During Period Value Payment Of Patent Legal Fees CommonStockIssuedDuringPeriodValuePaymentOfPatentLegalFees	110	USD
CY2006	skln	Common Stock Issued During Period Value Vendor Contractual Consideration CommonStockIssuedDuringPeriodValueVendorContractualConsideration	1451	USD
CY2006	skln	Common Stock Issued During Period Value Employment Agreement CommonStockIssuedDuringPeriodValueEmploymentAgreement	650	USD
CY2006	skln	Common Stock Issued During Period Value Investment CommonStockIssuedDuringPeriodValueInvestment	44810	USD
CY2002	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5000	USD
CY2008	skln	Value Of Common Stock Issued To Finders Agents ValueOfCommonStockIssuedToFindersAgents	0	USD
CY2008	skln	Common Stock Issued During Period Value Direct Legal Fees CommonStockIssuedDuringPeriodValueDirectLegalFees	0	USD
CY2008	skln	Common Stock Issued During Period Value Antidilution Provisions CommonStockIssuedDuringPeriodValueAntidilutionProvisions	0	USD
CY2008	skln	Common Stock Issued During Peirod Value Investor Relations CommonStockIssuedDuringPeirodValueInvestorRelations	87500	USD
CY2009	skln	Cumulative Effect Of Initial Adoption Of New Accounting Principles CumulativeEffectOfInitialAdoptionOfNewAccountingPrinciples	-479910	USD
CY2005	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	2793	USD
CY2006	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	13644	USD
CY2007	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	73907	USD
CY2008	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	354994	USD
CY2009	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	111835	USD
CY2010	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrants	11382	USD
CY2009	skln	Value Of Common Stock Issued Under Pmm April ValueOfCommonStockIssuedUnderPmmApril	1073905	USD
CY2007	skln	Capital Contributions Resulting From Waivers Of Debt CapitalContributionsResultingFromWaiversOfDebt	346714	USD
CY2008	skln	Capital Contributions Resulting From Waivers Of Debt CapitalContributionsResultingFromWaiversOfDebt	129684	USD
CY2009	skln	Capital Contributions Resulting From Waivers Of Debt CapitalContributionsResultingFromWaiversOfDebt	84600	USD
CY2009	skln	Value Of Equity Linked Financial Instruments Issued In Connection With Ppms ValueOfEquityLinkedFinancialInstrumentsIssuedInConnectionWithPpms	-222296	USD
CY2009	skln	Value Of Common Stock Issued To Consultant For Fund Raising ValueOfCommonStockIssuedToConsultantForFundRaising	0	USD
CY2009	skln	Value Of Common Stock Issued Upon Conversion Of Debt And Interest ValueOfCommonStockIssuedUponConversionOfDebtAndInterest	256454	USD
CY2010	skln	Value Of Common Stock Issued Under Ppm March ValueOfCommonStockIssuedUnderPpmMarch	177275	USD
CY2010	skln	Common Stock Issued To Consultants For Ir And Consulting CommonStockIssuedToConsultantsForIrAndConsulting	187045	USD
CY2010	skln	Value Of Equity Instruments Issued For Consulting Services ValueOfEquityInstrumentsIssuedForConsultingServices	354602	USD
CY2010	skln	Value Of Equity Linked Financial Instruments Issued In Connection With Ppm In First Quarter ValueOfEquityLinkedFinancialInstrumentsIssuedInConnectionWithPpmInFirstQuarter	-25553	USD
CY2010	skln	Value Of Common Stock Issued To Consultant In May ValueOfCommonStockIssuedToConsultantInMay	6425	USD
CY2010	skln	Value Of Common Stock Issued To Investors As Penalty For Late Registration ValueOfCommonStockIssuedToInvestorsAsPenaltyForLateRegistration	355124	USD
CY2007	skln	Value Of Equity Instruments Issued With Debt ValueOfEquityInstrumentsIssuedWithDebt	132938	USD
CY2009	skln	Value Of Equity Instruments Issued With Debt ValueOfEquityInstrumentsIssuedWithDebt	30150	USD
CY2010	skln	Value Of Equity Instruments Issued With Debt ValueOfEquityInstrumentsIssuedWithDebt	119474	USD
CY2013	skln	Value Of Equity Instruments Issued With Debt ValueOfEquityInstrumentsIssuedWithDebt	392556	USD
CY2010	skln	Value Of Equity Linked Financial Instruments Issued In Connection With Ppm In Second Quarter ValueOfEquityLinkedFinancialInstrumentsIssuedInConnectionWithPpmInSecondQuarter	-31332	USD
CY2013	skln	Shares Issued To Eleven Ppm Investors Converting Notes Par Value SharesIssuedToElevenPpmInvestorsConvertingNotesParValue	0.18
CY2010	skln	Value Of Equity Linked Financial Instruments Issued In Connection With Ppm In Third Quarter ValueOfEquityLinkedFinancialInstrumentsIssuedInConnectionWithPpmInThirdQuarter	-31506	USD
CY2010	skln	Value Of Common Stock Issued To Consultant In September ValueOfCommonStockIssuedToConsultantInSeptember	25000	USD
CY2010	skln	Value Of Common Stock Issued To Consultants In Third Quarter ValueOfCommonStockIssuedToConsultantsInThirdQuarter	107549	USD
CY2009	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4906	USD
CY2010	skln	Value Of Shares Issued November2010 Upon Exercise Of Warrants At135 Per Share ValueOfSharesIssuedNovember2010UponExerciseOfWarrantsAt135PerShare	17357	USD
CY2010	skln	Value Of Shares Issued To Directors As Compensation ValueOfSharesIssuedToDirectorsAsCompensation	45000	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm One ValueOfCommonStockIssuedUnderPpmOne	160000	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm Two ValueOfCommonStockIssuedUnderPpmTwo	18000	USD
CY2012	skln	Stock Issued During Period Value Private Investor Up On Conversion Of Note Payable Four In Second Quarter StockIssuedDuringPeriodValuePrivateInvestorUpOnConversionOfNotePayableFourInSecondQuarter	56584	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Up On Conversion Of Note Payable Two In Second Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUpOnConversionOfNotePayableTwoInSecondQuarter	12000	USD
CY2012	skln	Stock Issued Up On Conversion Of Debt Three In Value StockIssuedUpOnConversionOfDebtThreeInValue	59590	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm Three ValueOfCommonStockIssuedUnderPpmThree	15000	USD
CY2012	skln	Shares Issued To Director As Compensation SharesIssuedToDirectorAsCompensation	25000	USD
CY2012	skln	Shares Issued In Second Quarter Under Ppm SharesIssuedInSecondQuarterUnderPpm	690946	USD
CY2011	skln	Value Of Common Stock Issued Upon Conversion Of Debt In First Quarter ValueOfCommonStockIssuedUponConversionOfDebtInFirstQuarter	20000	USD
CY2011	skln	Value Of Common Stock Issued To Pay Interest On Debt One ValueOfCommonStockIssuedToPayInterestOnDebtOne	22500	USD
CY2010	skln	Increase In Additional Paid In Capital Vested Stock Options IncreaseInAdditionalPaidInCapitalVestedStockOptions	161107	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Up On Conversion Of Note Payable Three In Second Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUpOnConversionOfNotePayableThreeInSecondQuarter	18000	USD
CY2012	skln	Stock Issued During Period Value Private Investor Up On Conversion Of Note Payable Five In Second Quarter StockIssuedDuringPeriodValuePrivateInvestorUpOnConversionOfNotePayableFiveInSecondQuarter	9022	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	250000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Up On Conversion Of Note Payable Four In Second Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUpOnConversionOfNotePayableFourInSecondQuarter	33021	USD
CY2011	skln	Value Of Equity Instruments Issued To Consultants In First Quarter ValueOfEquityInstrumentsIssuedToConsultantsInFirstQuarter	91504	USD
CY2010	skln	Value Of Equity Instruments Issued To Consultants In Fourth Quarter ValueOfEquityInstrumentsIssuedToConsultantsInFourthQuarter	26234	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm ValueOfCommonStockIssuedUnderPpm	400000	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm Two In Second Quarter ValueOfCommonStockIssuedUnderPpmTwoInSecondQuarter	75000	USD
CY2011	skln	Stock Issued Upon Conversion Of Debt And Interest StockIssuedUponConversionOfDebtAndInterest	32000	USD
CY2011	skln	Value Of Equity Instruments Issued To Consultants In Second Quarter ValueOfEquityInstrumentsIssuedToConsultantsInSecondQuarter	12256	USD
CY2011	skln	Value Of Equity Instruments Issued To Consultants In Third Quarter ValueOfEquityInstrumentsIssuedToConsultantsInThirdQuarter	147116	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm One In Third Quarter ValueOfCommonStockIssuedUnderPpmOneInThirdQuarter	210000	USD
CY2011	skln	Value Of Common Stock Issued Under Ppm Four In Third Quarter ValueOfCommonStockIssuedUnderPpmFourInThirdQuarter	275000	USD
CY2011	skln	Value Of Restricted Stock Issued To Consultants In Third Quarter ValueOfRestrictedStockIssuedToConsultantsInThirdQuarter	55000	USD
CY2011	skln	Value Of Common Stock Issued Under Ir Compensation ValueOfCommonStockIssuedUnderIrCompensation	201250	USD
CY2011	skln	Value Of Equity Instrument Upon Conversion Of Accounts Payable In First Quarter ValueOfEquityInstrumentUponConversionOfAccountsPayableInFirstQuarter	20000	USD
CY2011	skln	Value Of Shares Issued To Private Investor In Fourth Quarter ValueOfSharesIssuedToPrivateInvestorInFourthQuarter	232000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable One In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableOneInFirstQuarter	8000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable Two In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableTwoInFirstQuarter	14000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable Three In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableThreeInFirstQuarter	15000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable Four In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableFourInFirstQuarter	16000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable Five In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableFiveInFirstQuarter	12000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable Six In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableSixInFirstQuarter	10000	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Upon Conversion Of Note Payable Seven In First Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUponConversionOfNotePayableSevenInFirstQuarter	8500	USD
CY2012	skln	Value Of Shares Issued To Private Investor In First Quarter ValueOfSharesIssuedToPrivateInvestorInFirstQuarter	600000	USD
CY2012	skln	Stock Issued During Period Value Consulting To Now Interim Ceo In First Quarter StockIssuedDuringPeriodValueConsultingToNowInterimCeoInFirstQuarter	19500	USD
CY2011	skln	Increase In Additional Paid In Capital Vested Stock Options And Warrants In First Quarter IncreaseInAdditionalPaidInCapitalVestedStockOptionsAndWarrantsInFirstQuarter	1937638	USD
CY2012	skln	Stock Issued During Period Value Institutional Investor Up On Conversion Of Note Payable One In Second Quarter StockIssuedDuringPeriodValueInstitutionalInvestorUpOnConversionOfNotePayableOneInSecondQuarter	10000	USD
CY2012	skln	Value Of Shares Issued To Private Investor In One Second Quarter ValueOfSharesIssuedToPrivateInvestorInOneSecondQuarter	39500	USD
CY2012	skln	Stock Issued Up On Conversion Of Debt One In Value StockIssuedUpOnConversionOfDebtOneInValue	493884	USD
CY2012	skln	Stock Issued Up On Conversion Of Debt Two In Value StockIssuedUpOnConversionOfDebtTwoInValue	185299	USD
CY2012	skln	Stock Issued During Period Value Private Investor Up On Conversion Of Note Payable One In Second Quarter StockIssuedDuringPeriodValuePrivateInvestorUpOnConversionOfNotePayableOneInSecondQuarter	1125000	USD
CY2012	skln	Stock Issued During Period Value Private Investor Up On Conversion Of Note Payable Two In Second Quarter StockIssuedDuringPeriodValuePrivateInvestorUpOnConversionOfNotePayableTwoInSecondQuarter	57042	USD
CY2012	skln	Stock Issued During Period Value Private Investor Up On Conversion Of Note Payable Three In Second Quarter StockIssuedDuringPeriodValuePrivateInvestorUpOnConversionOfNotePayableThreeInSecondQuarter	59534	USD
CY2012	skln	Value Of Common Stock Issued Under Ir Compensation One ValueOfCommonStockIssuedUnderIrCompensationOne	93750	USD
CY2012	skln	Stock Issued During Period Value Private Investor Up On Conversion Of Note Payable Six In Second Quarter StockIssuedDuringPeriodValuePrivateInvestorUpOnConversionOfNotePayableSixInSecondQuarter	50000	USD
CY2012	skln	Value Of Shares Issued As Settlement To Remove Anti Dilution Agreement ValueOfSharesIssuedAsSettlementToRemoveAntiDilutionAgreement	1722500	USD
CY2012	skln	Shares Issued In Settlement With Former Coo SharesIssuedInSettlementWithFormerCoo	142333	USD
CY2012	skln	Equity Value For Warrants Issued In Settlement To Former Ceo And Coo EquityValueForWarrantsIssuedInSettlementToFormerCeoAndCoo	150189	USD
CY2012	skln	Value Of Common Stock Issued Under Ir Compensation Two ValueOfCommonStockIssuedUnderIrCompensationTwo	21000	USD
CY2012	skln	Debt Conversion Converted Instruments Value DebtConversionConvertedInstrumentsValue	23563	USD
CY2012	skln	Value Of Shares Issued To Private Investor Exercise Of Stock Option ValueOfSharesIssuedToPrivateInvestorExerciseOfStockOption	718	USD
CY2012	skln	Value Of Shares Issued To Debtors As Compensation ValueOfSharesIssuedToDebtorsAsCompensation	156243	USD
CY2012	skln	Value Of Shares Issued Upon Conversion Of Notes Payable ValueOfSharesIssuedUponConversionOfNotesPayable	16526	USD
CY2012	skln	Value Of Shares Issued To Certified Shareholders List Per Transfer Agency ValueOfSharesIssuedToCertifiedShareholdersListPerTransferAgency	1	USD
CY2013	skln	Value Of Shares Issued To Debtors As Compensation One ValueOfSharesIssuedToDebtorsAsCompensationOne	43521	USD
CY2013	skln	Value Of Shares Issued Under Ppm To Five Investors ValueOfSharesIssuedUnderPpmToFiveInvestors	500000	USD
CY2013	skln	Stock Issued During Period Value Escrow Account Underlying Debt Agreement StockIssuedDuringPeriodValueEscrowAccountUnderlyingDebtAgreement	10000	USD
CY2013	skln	Value Of Shares Issued To Debtors As Compensation Two ValueOfSharesIssuedToDebtorsAsCompensationTwo	34550	USD
CY2013	skln	Stock Issued During Period Value Institutional Investor StockIssuedDuringPeriodValueInstitutionalInvestor	500000	USD
CY2013	skln	Adjustment To Additional Paid In Capital Value Of Shares Per Agreement With Officer AdjustmentToAdditionalPaidInCapitalValueOfSharesPerAgreementWithOfficer	40480	USD
CY2013	skln	Value Of Shares Issued To Debtors As Compensation Three ValueOfSharesIssuedToDebtorsAsCompensationThree	16750	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-2703264	USD
CY2002	skln	Common Stock Issued To Founders During Period Par Value CommonStockIssuedToFoundersDuringPeriodParValue	0.0167
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4130	USD
CY2002	skln	Stock Issued During Period Par Value New Issues StockIssuedDuringPeriodParValueNewIssues	1.67
CY2008	skln	Stock Issued During Period Par Value New Issues StockIssuedDuringPeriodParValueNewIssues	0.35
CY2003	skln	Common Stock Issued During Period Par Value Compensation For Loan Guarantees By Management CommonStockIssuedDuringPeriodParValueCompensationForLoanGuaranteesByManagement	0.0167
CY2013	skln	Commonstockissuedtoformerconsultantexercisingoption Commonstockissuedtoformerconsultantexercisingoption	2000	USD
CY2013	skln	Common Stock Issued To Former Ceo Exercising Options CommonStockIssuedToFormerCeoExercisingOptions	3333	USD
CY2013	skln	Shares Issued Upon Conversion Of Four Notes Payable SharesIssuedUponConversionOfFourNotesPayable	156243	USD
CY2013	skln	Share Value Issued For Interest To Four Notes Payable ShareValueIssuedForInterestToFourNotesPayable	11170	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants One StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsOne	2778	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants Two StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsTwo	1633	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants Three StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsThree	6327	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants Four StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsFour	2618	USD
CY2013	skln	Stock Issued During Period Value Issued To Twenty Four Warrant Holders StockIssuedDuringPeriodValueIssuedToTwentyFourWarrantHolders	1044490	USD
CY2013	skln	Stock Issued During Period Value Issued To Four Ppm Investors StockIssuedDuringPeriodValueIssuedToFourPpmInvestors	316504	USD
CY2013	skln	Stock Issued During Period Value Issued To Eleven Ppm Investors StockIssuedDuringPeriodValueIssuedToElevenPpmInvestors	1020200	USD
CY2013	skln	Stock Issued During Period Value Issued To Consultant As Compensation StockIssuedDuringPeriodValueIssuedToConsultantAsCompensation	57000	USD
CY2013	skln	Stock Issued During Period Value Issued For Two Note Conversion StockIssuedDuringPeriodValueIssuedForTwoNoteConversion	994928	USD
CY2013	skln	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	160715	USD
CY2013	skln	Stock Issued During Period Value Issued To Investors For Cashless Exercise Of Warrants StockIssuedDuringPeriodValueIssuedToInvestorsForCashlessExerciseOfWarrants	2044	USD
CY2013	skln	Stock Issued During Period Value Issued To Former Board Directors As Compensation StockIssuedDuringPeriodValueIssuedToFormerBoardDirectorsAsCompensation	100000	USD
CY2013	skln	Adjustments To Additional Paid In Capital Reduced Warrant Exercise Compensation Expense AdjustmentsToAdditionalPaidInCapitalReducedWarrantExerciseCompensationExpense	2140946	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	147500	USD
CY2013	skln	Stock Issued During Period Value Issued To One Investor For Cashless Exercise Of Warrants Two StockIssuedDuringPeriodValueIssuedToOneInvestorForCashlessExerciseOfWarrantsTwo	2778	USD
CY2013	skln	Stock Issued During Period Shares Cashless Exercise Of Warrants Five StockIssuedDuringPeriodSharesCashlessExerciseOfWarrantsFive	30244	USD
CY2002	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51057	USD
CY2003	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-90461	USD
CY2004	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-90353	USD
CY2005	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-123852	USD
CY2006	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-273026	USD
CY2007	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-752415	USD
CY2008	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1762628	USD
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2892230	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1352709	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4486879	USD
CY2002Q4	us-gaap	Stockholders Equity StockholdersEquity	-36057	USD
CY2003Q4	us-gaap	Stockholders Equity StockholdersEquity	-91118	USD
CY2004Q4	us-gaap	Stockholders Equity StockholdersEquity	-181361	USD
CY2005Q4	us-gaap	Stockholders Equity StockholdersEquity	-302170	USD
CY2006Q4	us-gaap	Stockholders Equity StockholdersEquity	-514641	USD
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	-712497	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	-309445	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	-2342030	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-2189557	USD
CY2005	skln	Common Stock Issued During Period Par Value Compensation For Loan Guarantees By Management CommonStockIssuedDuringPeriodParValueCompensationForLoanGuaranteesByManagement	0.0167
CY2003	skln	Common Stock Issued During Period Par Value Investment Including Finders Fee CommonStockIssuedDuringPeriodParValueInvestmentIncludingFindersFee	1.67
CY2004	skln	Common Stock Issued During Period Par Value Payment Of Patent Legal Fees CommonStockIssuedDuringPeriodParValuePaymentOfPatentLegalFees	0.0167
CY2006	skln	Common Stock Issued During Period Par Value Vendor Contractual Consideration CommonStockIssuedDuringPeriodParValueVendorContractualConsideration	0.0167
CY2006	skln	Common Stock Issued During Period Par Value Employment Agreements CommonStockIssuedDuringPeriodParValueEmploymentAgreements	0.0167
CY2006	skln	Common Stock Issued During Period Par Value Investment CommonStockIssuedDuringPeriodParValueInvestment	1.67
CY2007	skln	Stock Issued During Period Par Value Conversion Of Convertible Securities StockIssuedDuringPeriodParValueConversionOfConvertibleSecurities	1.67
CY2009	skln	Stock Issued During Period Par Value Conversion Of Convertible Securities StockIssuedDuringPeriodParValueConversionOfConvertibleSecurities	0.35
CY2008	skln	Common Stock Issued During Peirod Par Value Investor Relations CommonStockIssuedDuringPeirodParValueInvestorRelations	0.35
CY2009	skln	Par Value Of Common Stock Issued Under Pmm April ParValueOfCommonStockIssuedUnderPmmApril	0.50
CY2012	skln	Par Value Of Common Stock Issued Under Ppm May ParValueOfCommonStockIssuedUnderPpmMay	0.07
CY2009	skln	Par Value Of Common Stock Issued Upon Conversion Of Debt And Interest ParValueOfCommonStockIssuedUponConversionOfDebtAndInterest	0.27
CY2010	skln	Par Value Of Common Stock Issued Under Ppm March ParValueOfCommonStockIssuedUnderPpmMarch	0.50
CY2010	skln	Par Value Of Common Stock Issued To Consultants For Ir And Consulting ParValueOfCommonStockIssuedToConsultantsForIrAndConsulting	0.50
CY2010	skln	Par Value Of Common Stock Issued To Consultant In May ParValueOfCommonStockIssuedToConsultantInMay	0.50
CY2010	skln	Par Value Of Common Stock Issued Under Ppm April ParValueOfCommonStockIssuedUnderPpmApril	0.50
CY2010	skln	Par Value Of Common Stock Issued To Consultant In September ParValueOfCommonStockIssuedToConsultantInSeptember	0.10
CY2010	skln	Par Value Of Common Stock Issued To Consultants In Third Quarter ParValueOfCommonStockIssuedToConsultantsInThirdQuarter	0.22
CY2010	skln	Par Value Of Common Stock Issued Upon Exercise Of Warrants ParValueOfCommonStockIssuedUponExerciseOfWarrants	0.135
CY2010	skln	Par Value Of Common Stock Issued To Directors As Compensation ParValueOfCommonStockIssuedToDirectorsAsCompensation	0.15
CY2012	skln	Par Value Of Common Stock Issued To Directors As Compensation ParValueOfCommonStockIssuedToDirectorsAsCompensation	0.09
CY2013	skln	Par Value Of Common Stock Issued To Debtors As Compensation One ParValueOfCommonStockIssuedToDebtorsAsCompensationOne	0.15
CY2011	skln	Par Value Of Common Stock Issued Under Ppm One In First Quarter ParValueOfCommonStockIssuedUnderPpmOneInFirstQuarter	0.075
CY2011	skln	Par Value Of Common Stock Issued Under Ppm Two In First Quarter ParValueOfCommonStockIssuedUnderPpmTwoInFirstQuarter	0.085
CY2013	skln	Shares Issued To Consultant As Compensation Par Value SharesIssuedToConsultantAsCompensationParValue	0.38
CY2013	skln	Par Value Of Common Stock Issued Under Ppm To Five Investors ParValueOfCommonStockIssuedUnderPpmToFiveInvestors	0.07
CY2011	skln	Par Value Of Common Stock Issued Under Ppm Three In First Quarter ParValueOfCommonStockIssuedUnderPpmThreeInFirstQuarter	0.09
CY2011	skln	Par Value Of Common Stock Issued Under Ppm Four In First Quarter ParValueOfCommonStockIssuedUnderPpmFourInFirstQuarter	0.10
CY2011	skln	Par Value Of Common Stock Issued Under Ppm Two In Second Quarter ParValueOfCommonStockIssuedUnderPpmTwoInSecondQuarter	0.07
CY2011	skln	Par Value Of Common Stock Issued Under Ppm One In Third Quarter ParValueOfCommonStockIssuedUnderPpmOneInThirdQuarter	0.06
CY2011	skln	Par Value Of Common Stock Issued Under Ppm Three In Third Quarter ParValueOfCommonStockIssuedUnderPpmThreeInThirdQuarter	0.20
CY2011	skln	Par Value Of Common Stock Issued Upon Exercise Of Stock Options ParValueOfCommonStockIssuedUponExerciseOfStockOptions	0.01
CY2012	skln	Par Value Of Common Stock Issued Upon Exercise Of Stock Options ParValueOfCommonStockIssuedUponExerciseOfStockOptions	0.01
CY2011	skln	Par Value Of Common Stock Issued For Ir Compensation ParValueOfCommonStockIssuedForIrCompensation	0.35
CY2012	skln	Par Value Of Common Stock Issued For Ir Compensation ParValueOfCommonStockIssuedForIrCompensation	0.15
CY2011	skln	Par Value Of Common Stock Issued To Private Investor In Fourth Quarter ParValueOfCommonStockIssuedToPrivateInvestorInFourthQuarter	0.15
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable One CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableOne	0.1342
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable Two CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableTwo	0.13
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable Three CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableThree	0.088
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable Four CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableFour	0.0446
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable Five CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableFive	0.0446
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable Six CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableSix	0.0446
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Upon Conversion Of Note Payable Seven CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUponConversionOfNotePayableSeven	0.0397
CY2012	skln	Common Stock Issued During Period Par Value Private Investor In First Quarter CommonStockIssuedDuringPeriodParValuePrivateInvestorInFirstQuarter	0.065
CY2012	skln	Common Stock Issued During Period Par Value Consulting To Now Interim Ceo In First Quarter CommonStockIssuedDuringPeriodParValueConsultingToNowInterimCeoInFirstQuarter	0.065
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Up On Conversion Of Note Payable Eight CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUpOnConversionOfNotePayableEight	0.0286
CY2012	skln	Common Stock Issued During Period Par Value Private Investor Up On Conversion Of Note Payable One CommonStockIssuedDuringPeriodParValuePrivateInvestorUpOnConversionOfNotePayableOne	0.15
CY2012	skln	Common Stock Issued During Period Par Value Private Investor In Second Quarter One CommonStockIssuedDuringPeriodParValuePrivateInvestorInSecondQuarterOne	0.15
CY2012	skln	Shares Issued Upon Exercise Of Options During Period Par Value SharesIssuedUponExerciseOfOptionsDuringPeriodParValue	0.01
CY2012	skln	Common Stock Issued During Period Par Value Private Investor In Second Quarter Two CommonStockIssuedDuringPeriodParValuePrivateInvestorInSecondQuarterTwo	0.065
CY2012	skln	Stock Issued During Period Par Value Conversion Of Debt One StockIssuedDuringPeriodParValueConversionOfDebtOne	0.15
CY2012	skln	Stock Issued During Period Par Value Conversion Of Debt Two StockIssuedDuringPeriodParValueConversionOfDebtTwo	0.15
CY2012	skln	Common Stock Issued During Period Par Value Private Investor Up On Conversion Of Note Payable Two CommonStockIssuedDuringPeriodParValuePrivateInvestorUpOnConversionOfNotePayableTwo	0.18
CY2012	skln	Common Stock Issued During Period Par Value Private Investor Up On Conversion Of Note Payable Three CommonStockIssuedDuringPeriodParValuePrivateInvestorUpOnConversionOfNotePayableThree	0.052
CY2012	skln	Common Stock Issued During Period Par Value Private Investor Up On Conversion Of Note Payable Four CommonStockIssuedDuringPeriodParValuePrivateInvestorUpOnConversionOfNotePayableFour	0.10
CY2012	skln	Common Stock Issued During Period Par Value Private Investor Up On Conversion Of Note Payable Five CommonStockIssuedDuringPeriodParValuePrivateInvestorUpOnConversionOfNotePayableFive	0.032
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Up On Conversion Of Note Payable Nine CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUpOnConversionOfNotePayableNine	0.031
CY2012	skln	Stock Issued During Period Par Value Conversion Of Debt Three StockIssuedDuringPeriodParValueConversionOfDebtThree	0.15
CY2012	skln	Par Value Of Common Stock Issued Under Ppm In Second Quarter ParValueOfCommonStockIssuedUnderPpmInSecondQuarter	0.07
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Up On Conversion Of Note Payable Ten CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUpOnConversionOfNotePayableTen	0.0353
CY2012	skln	Common Stock Issued During Period Par Value Private Investor Up On Conversion Of Note Payable Six CommonStockIssuedDuringPeriodParValuePrivateInvestorUpOnConversionOfNotePayableSix	0.032
CY2012	skln	Common Stock Issued During Period Par Value Institutional Investor Up On Conversion Of Note Payable Eleven CommonStockIssuedDuringPeriodParValueInstitutionalInvestorUpOnConversionOfNotePayableEleven	0.0297
CY2012	skln	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	11021	USD
CY2012	skln	Par Value Share Issued As Settlement To Remove Antidilution Agreement ParValueShareIssuedAsSettlementToRemoveAntidilutionAgreement	0.065
CY2012	skln	Par Value Of Shares Issued In Settlement With Former Coo ParValueOfSharesIssuedInSettlementWithFormerCoo	0.15
CY2012	skln	Par Value Of Common Stock Issued To Debtors As Compensation ParValueOfCommonStockIssuedToDebtorsAsCompensation	0.10
CY2012	skln	Par Value Of Common Stock Issued To Conversion Of Notes Payable ParValueOfCommonStockIssuedToConversionOfNotesPayable	0.07
CY2013	skln	Par Value Of Common Stock Issued To Debtors As Compensation Two ParValueOfCommonStockIssuedToDebtorsAsCompensationTwo	0.15
CY2013	skln	Par Value Of Common Shares Issued To Institutional Investor ParValueOfCommonSharesIssuedToInstitutionalInvestor	0.07
CY2013	skln	Par Value Of Common Stock Issued To Debtors As Compensation Three ParValueOfCommonStockIssuedToDebtorsAsCompensationThree	0.067
CY2013	skln	Common Stock Issued To Former Consultant Exercising Option Par Value CommonStockIssuedToFormerConsultantExercisingOptionParValue	0.01
CY2013	skln	Common Stock Issued To Former Ceo Exercising Option Par Value CommonStockIssuedToFormerCeoExercisingOptionParValue	0.01
CY2013	skln	Shares Issued Upon Conversion Of Four Notes Payable Par Value SharesIssuedUponConversionOfFourNotesPayableParValue	0.15
CY2013	skln	Shares Issued For Interest To Four Notes Payable Par Value SharesIssuedForInterestToFourNotesPayableParValue	0.15
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value One SharesIssuedForCashlessExerciseOfWarrantsParValueOne	0.12
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Two SharesIssuedForCashlessExerciseOfWarrantsParValueTwo	0.16
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Three SharesIssuedForCashlessExerciseOfWarrantsParValueThree	0.15
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Four SharesIssuedForCashlessExerciseOfWarrantsParValueFour	0.2
CY2013	skln	Shares Issued To Twenty Four Warrant Holders Exercised At Reduced Par Value SharesIssuedToTwentyFourWarrantHoldersExercisedAtReducedParValue	0.1
CY2013	skln	Shares Issued For Two Note Conversions Par Value SharesIssuedForTwoNoteConversionsParValue	0.014
CY2013	skln	Shares Issued For Exercise Of Warrants Par Value SharesIssuedForExerciseOfWarrantsParValue	0.15
CY2013	skln	Shares Issued To Cashless Exercise Of Warrants Par Value SharesIssuedToCashlessExerciseOfWarrantsParValue	0.075
CY2013	us-gaap	Depreciation Depreciation	148761	USD
	us-gaap	Depreciation Depreciation	159405	USD
CY2013	skln	Shares Issued To Investor For Cashless Exercise Of Warrants Par Value SharesIssuedToInvestorForCashlessExerciseOfWarrantsParValue	0.17
CY2013	skln	Shares Issued To Former Board Directors As Compensation Par Value SharesIssuedToFormerBoardDirectorsAsCompensationParValue	0.325
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Five SharesIssuedForCashlessExerciseOfWarrantsParValueFive	0.10
CY2013	skln	Shares Issued To One Investor For Cashless Exercise Of Warrants Par Value Two SharesIssuedToOneInvestorForCashlessExerciseOfWarrantsParValueTwo	0.12
CY2013	skln	Shares Issued To Four Ppm Investors Converting Notes Par Value SharesIssuedToFourPpmInvestorsConvertingNotesParValue	0.12
CY2012	us-gaap	Depreciation Depreciation	1079	USD
CY2012	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	830372	USD
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3700070	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7197742	USD
CY2012	skln	Equity Instruments Issued For Management And Services EquityInstrumentsIssuedForManagementAndServices	3919828	USD
CY2013	skln	Equity Instruments Issued For Management And Services EquityInstrumentsIssuedForManagementAndServices	239290	USD
	skln	Equity Instruments Issued For Management And Services EquityInstrumentsIssuedForManagementAndServices	6029058	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	355124	USD
CY2012	skln	Conversion Of Accrued Liabilities To Capital ConversionOfAccruedLiabilitiesToCapital	0	USD
CY2013	skln	Conversion Of Accrued Liabilities To Capital ConversionOfAccruedLiabilitiesToCapital	0	USD
	skln	Conversion Of Accrued Liabilities To Capital ConversionOfAccruedLiabilitiesToCapital	476398	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	57518	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	413695	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	756497	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10583	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57534	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	97245	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	47604	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-23034	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	122175	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2739	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33179	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	60588	USD
CY2012	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	0	USD
CY2013	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	0	USD
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-14957	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	421104	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	429033	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2147872	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1039255	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	776548	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2494237	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	69000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	69000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1184165	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3855166	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10092697	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	162761	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	175019	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	53355	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	195850	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	0	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-216116	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-370869	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	528525	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1822718	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3935209	USD
CY2012	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	150000	USD
CY2013	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	75667	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	695794	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2337378	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6955977	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1074319	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4160096	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10565519	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-109846	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	88814	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	101953	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122985	USD
CY2002Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	100000	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	415775	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	515775	USD
CY2012	skln	Common Stock Issued For Accrued Interest CommonStockIssuedForAccruedInterest	106310	USD
CY2013	skln	Common Stock Issued For Accrued Interest CommonStockIssuedForAccruedInterest	402669	USD
	skln	Common Stock Issued For Accrued Interest CommonStockIssuedForAccruedInterest	620839	USD
CY2012	skln	Conversion Of Accounts Payable To Convertible Debt ConversionOfAccountsPayableToConvertibleDebt	0	USD
CY2013	skln	Conversion Of Accounts Payable To Convertible Debt ConversionOfAccountsPayableToConvertibleDebt	0	USD
	skln	Conversion Of Accounts Payable To Convertible Debt ConversionOfAccountsPayableToConvertibleDebt	546600	USD
CY2012	skln	Common Stock Issued To Satisfy Debt CommonStockIssuedToSatisfyDebt	817800	USD
CY2013	skln	Common Stock Issued To Satisfy Debt CommonStockIssuedToSatisfyDebt	2318568	USD
	skln	Common Stock Issued To Satisfy Debt CommonStockIssuedToSatisfyDebt	3538935	USD
CY2012	skln	Stock Warrant Issued To Satisfy Accounts Payable StockWarrantIssuedToSatisfyAccountsPayable	418644	USD
CY2013	skln	Stock Warrant Issued To Satisfy Accounts Payable StockWarrantIssuedToSatisfyAccountsPayable	100521	USD
	skln	Stock Warrant Issued To Satisfy Accounts Payable StockWarrantIssuedToSatisfyAccountsPayable	539165	USD
CY2012Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	0	USD
CY2013Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	280000	USD
CY2013	skln	Stock Issued During Period Value Issued For Interest On Two Note Conversion StockIssuedDuringPeriodValueIssuedForInterestOnTwoNoteConversion	7365	USD
CY2013	skln	Stock Issued During Period Value Issued In Settlement With Former Noteholder StockIssuedDuringPeriodValueIssuedInSettlementWithFormerNoteholder	102060	USD
CY2013	skln	Stock Issued During Period Value Issued To One Warrant Holders StockIssuedDuringPeriodValueIssuedToOneWarrantHolders	125000	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants Six StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsSix	5447	USD
CY2013	skln	Adjustment To Additional Paid In Capital Vesting Expense One AdjustmentToAdditionalPaidInCapitalVestingExpenseOne	1505270	USD
CY2012Q4	skln	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	USD
CY2013Q4	skln	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	USD
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Trading Symbol TradingSymbol	SKLN
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	221535194	shares
CY2013	dei	Entity Registrant Name EntityRegistrantName	Skyline Medical Inc.
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001446159
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	skln	Shares Issued In Settlement With Former Noteholder Par Value SharesIssuedInSettlementWithFormerNoteholderParValue	0.27
CY2013	skln	Shares Issued To Option Holder Par Value One SharesIssuedToOptionHolderParValueOne	0.065
CY2013Q2	dei	Entity Public Float EntityPublicFloat	11323394	USD
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2013	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.040	pure
CY2012	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1654	USD
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	32790	USD
CY2013Q4	skln	Repayments Of Notes Payable Due RepaymentsOfNotesPayableDue	450958	USD
CY2013Q4	skln	Repayments Of Notes Payable Due In Year One RepaymentsOfNotesPayableDueInYearOne	120000	USD
CY2013Q4	skln	Repayments Of Notes Payable Due In Year Two RepaymentsOfNotesPayableDueInYearTwo	120000	USD
CY2013Q4	skln	Secured Debt Common Stock Shares SecuredDebtCommonStockShares	666667	shares
CY2013	skln	Escrow Account Release Of Common Stock Shares Description EscrowAccountReleaseOfCommonStockSharesDescription	The escrow account releases 1/3 or 333,333 shares per year to the Company if there is no default.
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54	pure
CY2013	skln	Shares Issued For Interest On Conversion Of Two Note Conversions Par Value SharesIssuedForInterestOnConversionOfTwoNoteConversionsParValue	18
CY2013	skln	Shares Issued To One Warrant Holder Exercised At Reduced Par Value SharesIssuedToOneWarrantHolderExercisedAtReducedParValue	0.125
CY2013	skln	Shares Issued To Option Holder Par Value Two SharesIssuedToOptionHolderParValueTwo	0.07
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Six SharesIssuedForCashlessExerciseOfWarrantsParValueSix	0.075
CY2013Q4	skln	Share Based Compensation Arrangement By Share Based Payment Award Warrant Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantVestedAndExpectedToVestExercisableNumber	34643829	shares
CY2009	skln	Value Of Common Stock Issued To Pay For Fund Raising March ValueOfCommonStockIssuedToPayForFundRaisingMarch	0	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants Seven StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsSeven	1597	USD
CY2013	skln	Stock Issued During Period Value Cashless Exercise Of Warrants Eight StockIssuedDuringPeriodValueCashlessExerciseOfWarrantsEight	1167	USD
CY2013	skln	Stock Issued During Period Value Issued To Option Holder One StockIssuedDuringPeriodValueIssuedToOptionHolderOne	650	USD
CY2013	skln	Stock Issued During Period Value Issued To Option Holder Two StockIssuedDuringPeriodValueIssuedToOptionHolderTwo	1190	USD
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Seven SharesIssuedForCashlessExerciseOfWarrantsParValueSeven	0.13
CY2013	skln	Shares Issued For Cashless Exercise Of Warrants Par Value Eight SharesIssuedForCashlessExerciseOfWarrantsParValueEight	0.075
CY2013Q4	skln	Shares Issued To One Warrant Holder Exercised At Reduced Par Value SharesIssuedToOneWarrantHolderExercisedAtReducedParValue	0.125
CY2013Q4	skln	Stock Issued During Period Value Issued To One Warrant Holders StockIssuedDuringPeriodValueIssuedToOneWarrantHolders	125000	USD
CY2013Q4	skln	Stock Issued During Period Shares Issued To One Warrant Holders StockIssuedDuringPeriodSharesIssuedToOneWarrantHolders	1000000	shares
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12258	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	175019	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8737	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16909	USD
CY2013Q3	skln	Request To Issue Common Stock Shares To Group Of Partnership And Individuals During Period RequestToIssueCommonStockSharesToGroupOfPartnershipAndIndividualsDuringPeriod	4993814	shares
CY2013Q3	skln	Cashless Exercise Of Stock Purchase Warrants Total CashlessExerciseOfStockPurchaseWarrantsTotal	6184412	shares
CY2013Q4	skln	Common Stock Shares Outstanding Requested To Issue To Group Of Partnership And Individuals CommonStockSharesOutstandingRequestedToIssueToGroupOfPartnershipAndIndividuals	1264988	shares
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD

Files In Submission

Name	View Source	Status
0001144204-14-018035-index-headers.html	Edgar Link	pending
0001144204-14-018035-index.html	Edgar Link	pending
0001144204-14-018035.txt	Edgar Link	pending
0001144204-14-018035-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
skln-20131231.xml	Edgar Link	completed
skln-20131231.xsd	Edgar Link	pending
skln-20131231_cal.xml	Edgar Link	unprocessable
skln-20131231_def.xml	Edgar Link	unprocessable
skln-20131231_lab.xml	Edgar Link	unprocessable
skln-20131231_pre.xml	Edgar Link	unprocessable
v370643_10k.htm	Edgar Link	pending
v370643_ex23-1.htm	Edgar Link	pending
v370643_ex31-1.htm	Edgar Link	pending
v370643_ex31-2.htm	Edgar Link	pending
v370643_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POAI
Predictive Oncology Inc. Stock $poai

2013 Q4 Form 10-K Financial Statement

#000114420414018035 Filed on March 27, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI Predictive Oncology Inc. Stock $poai

2013 Q4 Form 10-K Financial Statement

#000114420414018035 Filed on March 27, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI
Predictive Oncology Inc. Stock $poai